10.29.24 -- Suppliers Pushing Novel Analytical Methods Testing Forward

Review a well-established platform process for lentiviral vector (LV) production based on transient transfection of serum-free cells grown in suspension.

Standardized methods, materials, and analytics are critical for overcoming hurdles in the gene therapy space. Explore how a platform approach to fast-track AAVs can enhance quality and efficiency.

The complex nature of ADCs necessitates meticulous attention to CMC. Gain valuable insights for navigating CMC development, ensuring the delivery of safe and efficacious biopharmaceutical products.

Explore unique infrastructure around safety operations and quality, with a focus on a new product introduction process with respect to risk assessment.

CDMOs help reduce the complexity and costs of drug development and manufacturing, making the right CDMO partner essential for many biopharma companies.

A successful technology transfer sets the stage for GMP production and opens the door to process performance qualification campaigns and licensure.

Dive into the evolution and future potential of microbial manufacturing in the biopharmaceutical industry to discover how digital tools can revolutionize development and production processes.

Intensified adherent cell culture offers a promising solution to the limitations of traditional suspension culture, with the potential to improve efficiency, reduce costs, and accelerate development.

Blending pharmaceuticals and medical devices into a single product offers immense potential for patient care, but manufacturing these combination products presents unique hurdles.

From identity and purity testing using chromatography and electrophoresis to PCR and microbial studies, explore advanced analytical solutions tailored for siRNA, miRNA, pDNA, and mRNA products.

By partnering with a trusted company that offers expertise in navigating the challenges of scale up, drug developers can have confidence in their ability to successfully bring their products to market.

With a growing interest in developing new and improved bioconjugate drugs, explore an “innovation through collaboration” approach that can facilitate access to next-generation conjugation technologies.

Are you searching for a better way to calculate growth rate? Explore a new approach that performs the rate calculations using a simple method to correct for volume changes.

In addition to streamlining processes and implementing new technologies, new facility design provides tremendous opportunity to positively impact client timelines, costs, and options for flexibility.